Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
2.300
+0.130 (5.99%)
At close: Oct 9, 2025, 4:00 PM EDT
2.280
-0.020 (-0.87%)
After-hours: Oct 9, 2025, 7:59 PM EDT
Jaguar Health Market Cap
Jaguar Health has a market cap or net worth of $5.00 million as of October 9, 2025. Its market cap has decreased by -50.34% in one year.
Market Cap
5.00M
Enterprise Value
33.33M
1-Year Change
-50.34%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since October 5, 2018, Jaguar Health's market cap has decreased from $13.36M to $5.00M, a decrease of -62.55%. That is a compound annual growth rate of -13.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 5.00M | -58.02% |
| Dec 31, 2024 | 11.92M | 55.07% |
| Dec 29, 2023 | 7.68M | -41.52% |
| Dec 30, 2022 | 13.14M | -72.54% |
| Dec 31, 2021 | 47.85M | -44.06% |
| Dec 31, 2020 | 85.54M | 619.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |